You just read:

Alder Biopharmaceuticals' ALD518 Antibody Therapeutic Reduces Disease Symptoms, Anemia in Phase 2a Clinical Trial in Non-Small Cell Lung Cancer Patients

News provided by

Alder Biopharmaceuticals Inc.

Jun 06, 2010, 08:00 ET